Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The High Affinity CXCR4 Inhibitor, BL-8040, Induces Apoptosis of AML Blasts and Their Terminal Differentiation By Blocking AKT/ERK Survival Signals and Downregulating BCL-2, MCL-1 and Cyclin-D1 through Regulation of Mir-15a/16-1 Expression

Michal Abraham, PhD, Shiri Klein, Baruch Bulvik, Hanna Wald, Dvora Holam, Lola Weiss, Katia Beider, PhD, Orly Eizenberg, Ori Wald, MD PhD, Abraham Avigdor, MD, Ohad Benjamini, MD, Eithan Galun, MD, Arnon Nagler, Yaron Pereg, PhD, Amnon Peled, PhD

Blood (2016) 128 (22): 767.

https://doi.org/10.1182/blood.V128.22.767.767

Published: 2016

Journal Articles

CXCR4 Promotes the Tumorogenicity of Multiple Myeloma, Including Increased Motility, Clonogenicity, up-Regulation of VLA-4, Protection From Chemotherapy and Aggressive Tumor Development In Vivo

Katia Beider, Amnon Peled, PhD, Lola Weiss, Merav Leiba, Avichai Shimoni, MD, Arnon Nagler

Blood (2011) 118 (21): 1801.

https://doi.org/10.1182/blood.V118.21.1801.1801

Published: 2011

Journal Articles

Ex-Vivo UVA Treated Donor T-Cells for the Induction of Graft Versus Leukemia Effect in Murine Model and Clinical Application

Si mcha Samuel, Lola Weiss, Osnat Hazan, Igor B Resnick, Michael Y. Shapira, MD, Benjamin Gesundheit, Lilane Dray, Reuven Or

Blood (2008) 112 (11): 4618.

https://doi.org/10.1182/blood.V112.11.4618.4618

Published: 2008

Journal Articles

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Michael Y. Shapira, MD, Lola Weiss, PhD, Shoshana Reich, Michael Zeira, PhD, Shimon Slavin, MD

Blood (2006) 108 (11): 5171.

https://doi.org/10.1182/blood.V108.11.5171.5171

Published: 2006

Journal Articles

Fludarabine Monophosphate Reduces the Incidence and Severity of Graft-Versus-Host Disease in a Murine Model of Bone Marrow Transplantation

Reuven Or, Lola Weiss, Shai Teiman

Blood (1997) 90 (1): 471.

https://doi.org/10.1182/blood.V90.1.471

Published: 1997

NARROW

The High Affinity CXCR4 Inhibitor, BL-8040, Induces Apoptosis of AML Blasts and Their Terminal Differentiation By Blocking AKT/ERK Survival Signals and Downregulating BCL-2, MCL-1 and Cyclin-D1 through Regulation of Mir-15a/16-1 Expression

CXCR4 Promotes the Tumorogenicity of Multiple Myeloma, Including Increased Motility, Clonogenicity, up-Regulation of VLA-4, Protection From Chemotherapy and Aggressive Tumor Development In Vivo

Ex-Vivo UVA Treated Donor T-Cells for the Induction of Graft Versus Leukemia Effect in Murine Model and Clinical Application

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Fludarabine Monophosphate Reduces the Incidence and Severity of Graft-Versus-Host Disease in a Murine Model of Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

The High Affinity CXCR4 Inhibitor, BL-8040, Induces Apoptosis of AML Blasts and Their Terminal Differentiation By Blocking AKT/ERK Survival Signals and Downregulating BCL-2, MCL-1 and Cyclin-D1 through Regulation of Mir-15a/16-1 Expression

CXCR4 Promotes the Tumorogenicity of Multiple Myeloma, Including Increased Motility, Clonogenicity, up-Regulation of VLA-4, Protection From Chemotherapy and Aggressive Tumor Development In Vivo

Ex-Vivo UVA Treated Donor T-Cells for the Induction of Graft Versus Leukemia Effect in Murine Model and Clinical Application

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Fludarabine Monophosphate Reduces the Incidence and Severity of Graft-Versus-Host Disease in a Murine Model of Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only